動物用ワクチンの市場レポート：ワクチンの種類、技術、投与経路、流通チャネル、地域別、2025年～2033年

世界の動物用ワクチン市場規模は2024年に147億米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は7.71%で、2033年には296億米ドルに達すると予測しています。市場を牽引している主な要因は、獣医ヘルスケアへの注目の高まり、家畜保険の必要性、新しい獣医学的予防接種の発売です。現在、北米が市場を独占しているのは、ペットを飼う親が増加していること、高度な獣医ヘルスケアインフラが整備されていること、畜産業が盛んであることによる。

動物用ワクチンは、非経口および経口経路を通じて家畜や野生種に投与され、病気そのものを引き起こすことなく防御免疫反応を刺激する、生物学的に調製された予防接種を表します。不活化ワクチン、弱毒生ワクチン、遺伝子組換えワクチンなどが一般的です。これらの接種は、動物の苦痛を軽減し、免疫効率を高め、様々な伝染性の人獣共通感染症の開発・伝播のリスクを予防するのに役立っています。

動物用ワクチン市場動向：

動物用ヘルスケアへの注目の高まり

IMARC Groupのレポートによると、世界の動物用ヘルスケア市場は2023年に433億米ドルに達しました。ペットを飼う人が増えるにつれ、ペットの健康が重視されるようになり、その結果、動物病院での診察や予防治療が増加しています。予防接種はペットの健康維持の重要な側面であり、これが動物用予防接種の需要を牽引しています。動物の病気を単に治療するのではなく、予防することの必要性に対する大衆の意識の高まりは、動物用ワクチン市場の見通しを良好なものにしています。ワクチン接種は非常に効率的な予防手段であり、コンパニオンアニマルおよび家畜の両方にとって、獣医学的ヘルスケアレジメンの不可欠な要素となっています。ペットの親や家畜生産者は、動物の健康や生産性に害を及ぼす可能性のある病気を予防するために、ワクチンを含むヘルスケアに多くの費用を支払うことを望んでいます。このような傾向は、特に獣医療サービスがより利用しやすくなるにつれて、様々な予防接種の需要を喚起しています。

家畜保険への需要の高まり

IMARC Groupのレポートによると、世界の家畜保険市場は2023年に36億米ドルに達しました。多くの家畜保険は、一般的な病気に対するワクチン接種を保険適用の条件としています。被保険者である農家や家畜の所有者は、保険の義務を果たすために家畜にワクチンを接種するインセンティブを与えられており、これが動物用ワクチン市場シェアにプラスの影響を与えています。家畜保険は一般に、病気や事故、自然災害による家畜の損失に伴う経済的リスクを軽減するために利用されます。家畜にワクチンを接種している農家は、家畜が病気にかかる可能性が低くなるため、家畜が保険に加入しやすくなり、保険金を請求される可能性が低くなります。これにより定期的なワクチン接種が促進され、ワクチン需要が増加します。

新発売

新しい動物用予防接種は、開発中の疾病や新たに発見された家畜に影響を与える病原体と闘うために製造されています。これまで知られていなかった病気や新興国での病気の発生に伴い、新しいワクチンの需要が高まり、それが動物用ワクチン市場の成長を促進しています。組み換えワクチン、DNAワクチン、ベクターベースのワクチンなどの次世代ワクチンは、動物における疾病予防の有効性と安全性を向上させる。これらの新しいワクチンは、より効果的で副作用が少なく、予防効果が長持ちすることが多いため、医師や飼い主にとってより魅力的なものとなっています。新発売のワクチンには、1回の接種で多くの病気や系統をカバーするものが多く、獣医や飼い主の負担を軽減しています。

本レポートで扱う主な質問

• 世界の動物用ワクチン市場はこれまでどのように推移し、今後どのように推移していくのか？
• COVID-19が世界の動物用ワクチン市場に与えた影響は？
• 主要な地域市場とは？
• ワクチンの種類別の市場内訳は？
• 技術別の市場内訳は？
• 投与経路別の市場内訳は？
• 流通チャネル別の市場内訳は？
• 業界のバリューチェーンにおける様々な段階とは？
• 業界の主な促進要因と課題は何か？
• 世界の動物用ワクチン市場の構造と主要企業は？
• 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の動物用ワクチン市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：ワクチンの種類別

• 家畜ワクチン
  • 主要セグメント
    • 牛ワクチン
    • 家禽ワクチン
    • 豚ワクチン
    • その他
• コンパニオンアニマルワクチン
  • 主要セグメント
    • 犬のワクチン
    • 猫のワクチン
    • 馬のワクチン

第7章 市場内訳：技術別

• 弱毒生ワクチン
• 不活化ワクチン
• トキソイドワクチン
• 組み換えワクチン
• その他

第8章 市場内訳：投与経路別

• 皮下
• 筋肉内
• 鼻腔内

第9章 市場内訳：流通チャネル別

• 動物病院
• 獣医クリニック
• 薬局とドラッグストア
• その他

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Virbac SA
  • Zoetis Inc.

List of Figures

• Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
• Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2024
• Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2024
• Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2024
• Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2024
• Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2024
• Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
• Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2024
• Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
• Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
• Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
• Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
• Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
• Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 7: Global: Veterinary Vaccines Market: Competitive Structure
• Table 8: Global: Veterinary Vaccines Market: Key Players

The global veterinary vaccines market size reached USD 14.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033. The market is driven primarily because of the growing focus on veterinary healthcare, need for livestock insurance and the launch of new veterinary vaccinations. At present, North America dominates the market because of the rising number of pet parents, advanced veterinary healthcare infrastructure, and significant livestock industry.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases.

Veterinary Vaccines Market Trends:

Growing focus on veterinary healthcare

According to the IMARC Group's report, the global veterinary healthcare market reached USD 43.3 Billion in 2023. As more individuals are becoming pet parents, there is a greater emphasis on their well-being, resulting in increased veterinary appointments and preventive treatment. Vaccinations are an important aspect of keeping pets healthy, which is driving the demand for veterinary vaccinations. The growing awareness among the masses about the necessity of preventing animal diseases rather than simply treating them is offering a favorable veterinary vaccines market outlook. Vaccination is a very efficient preventive measure, making it an essential component of veterinary healthcare regimens for both companion animals and cattle. Pet parents and livestock producers are willing to pay more on healthcare, including vaccines, to prevent diseases that could harm animal health and productivity. This tendency is catalyzing the demand for a wide variety of immunizations, particularly as veterinary services become more accessible.

Increasing demand for livestock insurance

The IMARC Group's report shows that the global livestock insurance market reached USD 3.6 Billion in 2023. Many livestock insurance policies demand vaccinations against common diseases as a condition of coverage. Insured farmers and livestock owners are incentivized to vaccinate their animals to meet policy obligations, which is positively influencing the veterinary vaccines market share. Livestock insurance is generally used to reduce the financial risks connected with livestock loss caused by disease, accidents, or natural catastrophes. Farmers who vaccinate their animals lessen the chance of disease outbreaks, making their livestock more insurable and lowering the possibility of claims. This encourages regular vaccinations, which increases vaccine demand.

New launches

New veterinary vaccinations are being produced to combat developing diseases and newly discovered pathogens impacting animals. As outbreaks of previously unknown or developing illnesses are arising, the demand for novel vaccines is rising, thereby propelling veterinary vaccines market growth. Next-generation vaccines, such as recombinant, DNA, and vector-based vaccinations, improve the efficacy and safety of disease prevention in animals. These new vaccines are frequently more effective, have fewer side effects, and give longer-lasting protection, making them more appealing to physicians and pet owners. New releases frequently feature vaccines that cover many diseases or strains in a single shot, making life easier for vets and owners.

Key Market Segmentation:

Breakup by Vaccine Type:

• Livestock Vaccines
  • Bovine Vaccines
  • Poultry Vaccines
  • Porcine Vaccines
  • Others
• Companion Animal Vaccines
  • Canine Vaccines
  • Feline Vaccines
  • Equine Vaccines

Breakup by Technology:

• Attenuated Live Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Others

Breakup by Route of Administration:

• Subcutaneous
• Intramuscular
• Intranasal

Breakup by Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug Stores
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global veterinary vaccines market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• HIPRA
• Indian Immunologicals Limited
• Merck & Co. Inc.
• Neogen Corporation
• Phibro Animal Health Corporation
• Virbac SA
• Zoetis Inc.

Key Questions Answered in This Report:

• How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global veterinary vaccines market?
• What are the key regional markets?
• What is the breakup of the market based on the vaccine type?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the route of administration?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global veterinary vaccines market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Vaccine Type

• 6.1 Livestock Vaccines
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Bovine Vaccines
    • 6.1.2.2 Poultry Vaccines
    • 6.1.2.3 Porcine Vaccines
    • 6.1.2.4 Others
  • 6.1.3 Market Forecast
• 6.2 Companion Animal Vaccines
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Canine Vaccines
    • 6.2.2.2 Feline Vaccines
    • 6.2.2.3 Equine Vaccines
  • 6.2.3 Market Forecast

7 Market Breakup by Technology

• 7.1 Attenuated Live Vaccines
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Inactivated Vaccines
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Toxoid Vaccines
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Recombinant Vaccines
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

• 8.1 Subcutaneous
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Intramuscular
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Intranasal
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 Veterinary Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Veterinary Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Pharmacies and Drug Stores
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Boehringer Ingelheim International GmbH
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Ceva Sante Animale
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Elanco Animal Health Incorporated
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
  • 15.3.4 Hester Biosciences Limited
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
  • 15.3.5 HIPRA
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Indian Immunologicals Limited
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Merck & Co. Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
  • 15.3.8 Neogen Corporation
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Phibro Animal Health Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Virbac SA
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
  • 15.3.11 Zoetis Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials